Utah enhanced its Right-to-Try framework with explicit stem cell informed consent rules in 2024.
Statute
Utah Code Title 58 Ch. 85 (2015), SB 199 (2024)
Effective
Right-to-Try since 2015, SB 199 effective 2024
Utah's Right-to-Try statute permits investigational treatment for terminal illness, and the 2024 SB 199 amendment requires healthcare providers to give patients written notice and obtain signed consent before performing any stem cell therapy not approved by the FDA. The framework gives patients access while building a strong consent record.
The requirements below are set by Utah Code Title 58 Ch. 85 (2015), SB 199 (2024). Compliance is the responsibility of each individual treating physician under their state license.
Statutory compliance does not equal FDA approval. The procedures discussed are investigational and have not been approved by the US Food and Drug Administration.
All procedures discussed are investigational and are not approved by the US Food and Drug Administration. Outcomes vary by patient and are not predictable in advance. Whether a procedure is appropriate is a decision made by the treating physician.
An investigational cellular procedure being explored for adults with knee osteoarthritis. Outcomes vary by patient and are not guaranteed.
Learn more OrthopedicAn investigational cellular procedure being explored for adults with partial-thickness rotator cuff tendon conditions. Outcomes vary and are not guaranteed.
Learn more PainAn investigational cellular procedure being explored for adults with chronic, imaging-documented low back pain. Outcomes vary and are not guaranteed.
Learn more OrthopedicAn investigational cellular procedure being explored for adults with chronic lateral or medial epicondylitis. Outcomes vary by patient.
Learn more OrthopedicAn investigational cellular procedure being explored for adults with hip osteoarthritis. Outcomes vary and are not guaranteed.
Learn moreUtah has enacted Utah Code Title 58 Ch. 85 (2015), SB 199 (2024), which sets out specific conditions under which a state-licensed physician may practice in this area. The procedures discussed here are investigational and have not been approved by the US Food and Drug Administration.
No. Adults may travel to Utah from any US state for an in-person consultation with a network physician. Whether any procedure is appropriate is a clinical decision determined by the treating physician.
Cost depends on the indication, the cell product, and the treating physician. Each physician sets their own pricing and provides a written estimate. Select Stem Cell does not collect medical fees on behalf of physicians.
Yes. Utah law requires the treating physician to provide written disclosure of investigational status and obtain informed consent prior to any procedure.
Continue Reading